Shares of OTCBB:GTHP remained flat at $$0.01 during trading on Thursday. 1,040,000 shares of the stock were exchanged, compared to its average volume of 4,191,899. Guided Therapeutics has a 12 month low of $0.01 and a 12 month high of $0.52.
About Guided Therapeutics
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. The company focuses on marketing LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.